Investcub personal page - To The Moon

Investcub

Investcub

No personal profile

330Follow

38Followers

1Topic

0Badge

2021-06-25

$SEMBCORP MARINE LTD(S51.SI)$Trying to average it out….hopefully things will get better

2021-08-12

Have not heard of these companies before…[Happy]

Sorry, the original content has been removed

2021-06-23

$SEMBCORP MARINE LTD(S51.SI)$Is the change really gonna come this time?

2021-07-18

Truly an important set of tips to all investors…having the cash to buy the dip is definitely key

Sorry, the original content has been removed

2021-07-12

Bracing for the storm…

Chase, Delta, Goldman Sachs, PepsiCo, and Other Stocks to Watch This Week

2021-08-31

$Alibaba(BABA)$Still holding …come on Baba…

2021-06-15

$AMC Entertainment(AMC)$Steady …steady….prove them all wrong

2021-07-16

Waiting the dip to go lower ….before buying, perhaps…

Why NVIDIA Stock Just Dropped 4%

2021-07-05

$SEMBCORP MARINE LTD(S51.SI)$Hoping for a positive start to the week ….

2021-07-04

$Orbital Energy Group(OEG)$Should I dollar costaverage….? With the hope that it will recover?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3584582153384625","uuid":"3584582153384625","gmtCreate":1621488156539,"gmtModify":1625468765802,"name":"Investcub","pinyin":"investcub","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":38,"headSize":330,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.32%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.08","exceedPercentage":"93.19%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9941981183,"gmtCreate":1679918336142,"gmtModify":1679918338542,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/OIG\">$Orbital Infrastructure Group, Inc.(OIG)$&nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/OIG\">$Orbital Infrastructure Group, Inc.(OIG)$&nbsp;</a>","text":"$Orbital Infrastructure Group, Inc.(OIG)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9941981183","isVote":1,"tweetType":1,"viewCount":2533,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9967472855,"gmtCreate":1670374244377,"gmtModify":1676538354483,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$&nbsp;</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$&nbsp;</a><v-v data-views=\"1\"></v-v>","text":"$Alibaba(BABA)$","images":[{"img":"https://community-static.tradeup.com/news/96ae343b1ea8f5da18f5e7fb375bb765","width":"750","height":"1249"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9967472855","isVote":1,"tweetType":1,"viewCount":2047,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026438335,"gmtCreate":1653414560027,"gmtModify":1676535277111,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/OEG\">$Orbital Energy Group(OEG)$</a>😔","listText":"<a href=\"https://ttm.financial/S/OEG\">$Orbital Energy Group(OEG)$</a>😔","text":"$Orbital Energy Group(OEG)$😔","images":[{"img":"https://community-static.tradeup.com/news/afbe1663b0bf5c59af6abefdf6551146","width":"828","height":"1632"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026438335","isVote":1,"tweetType":1,"viewCount":3022,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3580011914778910","authorId":"3580011914778910","name":"VivianChua","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":1,"idStr":"3580011914778910","authorIdStr":"3580011914778910"},"content":"will recover 💚","text":"will recover 💚","html":"will recover 💚"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026431530,"gmtCreate":1653414439120,"gmtModify":1676535277104,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$</a>To the sky pls...","listText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$</a>To the sky pls...","text":"$Alibaba(BABA)$To the sky pls...","images":[{"img":"https://community-static.tradeup.com/news/a9c85fb50b60fbdb692dbabcb7bf44a5","width":"750","height":"2627"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026431530","isVote":1,"tweetType":1,"viewCount":2699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9030481474,"gmtCreate":1645785280000,"gmtModify":1676534064066,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Bracing ... 🤕","listText":"Bracing ... 🤕","text":"Bracing ... 🤕","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030481474","repostId":"1185987372","repostType":4,"repost":{"id":"1185987372","kind":"news","pubTimestamp":1645783612,"share":"https://ttm.financial/m/news/1185987372?lang=en_US&edition=fundamental","pubTime":"2022-02-25 18:06","market":"us","language":"en","title":"U.S. Stocks Poised to Fall as Russia Continues Ukraine Onslaught","url":"https://stock-news.laohu8.com/highlight/detail?id=1185987372","media":"The Wall Street Journal","summary":"Stock futures decline, while Russian shares jump and oil prices edge higherU.S. stocks were poised f","content":"<html><head></head><body><p>Stock futures decline, while Russian shares jump and oil prices edge higher</p><p><img src=\"https://static.tigerbbs.com/1e9ee2e50f421d60d5ee0a2e060e8607\" tg-width=\"1184\" tg-height=\"692\" width=\"100%\" height=\"auto\"/></p><p>U.S. stocks were poised for further volatility, as investors sought to make sense of the potentially far-reaching implications of war in Ukraine for individual companies and the wider economy.</p><p>Futures for the S&amp;P 500 fell 1.2% Friday, a day after the benchmark index capped a wild trading session by closing 1.5% higher, as investors piled into growth and technology stocks. Futures for the Dow Jones Industrial Average fell 1% and those for the technology-focused Nasdaq-100 lost 1.4% Friday.</p><p>Overseas, markets regained some poise after sanctions laid out by President Bidenstopped short of some of the most severe measures investors had thought might be on the table. Russia’s Moex stock-market gauge, which endured a historic blow Thursday, rose 12.9%.</p><p>The Stoxx Europe 600 rose 0.7%, led by shares of resource and travel companies. Japan’s Nikkei 225 rose 2%, and the CSI 300, which comprises the largest stocks listed in Shanghai and Shenzhen, rose 1%, after both fell Thursday. Hong Kong’s Hang Seng Index slipped 0.6%.</p><p>In energy markets, futures for Brent crude, the global oil benchmark, rose 1.5% to $96.81 a barrel, while European natural-gas prices retreated by almost a quarter after rocketing Thursday.Brent topped $100 a barrel early Thursday before falling back.</p><p>Russian forces renewed bombing Ukraine early Friday, with central Kyiv rocked by explosions. Investors are pondering how the fighting, its effect on commodity markets and retaliatory Western sanctions will ripple through a world economy already grappling with elevated inflation and coming interest-rate rises by major central banks.</p><p>The U.S. and its allies have laid out stiff restrictions on Russian companies and their ability to interact with the international financial system. The European Union will formally sign off on sanctions Friday that willc ut 70% of Russia’s banking system off from international financial markets. Officials in Ukraine, the Baltics and the U.K. are calling for the sanctions to go further, cutting Russia off completely from infrastructure that ties together banks around the world.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b508620b24a78a56758f2e1dd2935e59\" tg-width=\"1050\" tg-height=\"699\" width=\"100%\" height=\"auto\"/><span>Investors are pondering how sanctions will affect the global economy.</span></p><p>“I do not think that this highly volatile period is already coming to an end,” said Daniel Egger, chief investment officer at St. Gotthard Fund Management. “Right now we have to focus now on what’s happening in Kyiv, how bloody the coming days will be, and I would say definitely the Russian sanctions still can be stepped up.”</p><p>In bond markets, yields fell in a sign investors still sought the safety of safe-haven assets. The yield on the benchmark U.S. 10-year Treasury note declined to 1.949% from 1.969% Thursday. Yields and prices move inversely. Gold prices, however, slipped 0.7% to $1,914 a troy ounce.</p><p>Among individual European stocks, some companies that were hammered at the start of Russia’s attack clawed back some lost ground. Russian gold producer Polymetal International rose 14%. Hungarian budget airline Wizz Air rose 4.9%. But banks with exposure to Russia or commodity markets came under pressure, including ING Groep,Société Générale and UniCredit. Shares of British arms and aerospace company BAE Systems, which has gained on the prospect of higher defense spending, added a further 4.3%.</p><p>“It looks like the military action in Ukraine could be protracted,” said Yung-Yu Ma, chief investment strategist for BMO Wealth Management in the U.S. In this case, short-term market movement is difficult to predict, he said.</p><p>Rapid inflation and the prospect of tighter monetary policy were complicating the outlook for some traditional safe-haven assets such as Treasury bonds, the U.S. dollar and gold, Mr. Ma added.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stocks Poised to Fall as Russia Continues Ukraine Onslaught</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stocks Poised to Fall as Russia Continues Ukraine Onslaught\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 18:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/global-stocks-markets-dow-update-02-25-22-11645771218?page=1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock futures decline, while Russian shares jump and oil prices edge higherU.S. stocks were poised for further volatility, as investors sought to make sense of the potentially far-reaching ...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stocks-markets-dow-update-02-25-22-11645771218?page=1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.wsj.com/articles/global-stocks-markets-dow-update-02-25-22-11645771218?page=1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185987372","content_text":"Stock futures decline, while Russian shares jump and oil prices edge higherU.S. stocks were poised for further volatility, as investors sought to make sense of the potentially far-reaching implications of war in Ukraine for individual companies and the wider economy.Futures for the S&P 500 fell 1.2% Friday, a day after the benchmark index capped a wild trading session by closing 1.5% higher, as investors piled into growth and technology stocks. Futures for the Dow Jones Industrial Average fell 1% and those for the technology-focused Nasdaq-100 lost 1.4% Friday.Overseas, markets regained some poise after sanctions laid out by President Bidenstopped short of some of the most severe measures investors had thought might be on the table. Russia’s Moex stock-market gauge, which endured a historic blow Thursday, rose 12.9%.The Stoxx Europe 600 rose 0.7%, led by shares of resource and travel companies. Japan’s Nikkei 225 rose 2%, and the CSI 300, which comprises the largest stocks listed in Shanghai and Shenzhen, rose 1%, after both fell Thursday. Hong Kong’s Hang Seng Index slipped 0.6%.In energy markets, futures for Brent crude, the global oil benchmark, rose 1.5% to $96.81 a barrel, while European natural-gas prices retreated by almost a quarter after rocketing Thursday.Brent topped $100 a barrel early Thursday before falling back.Russian forces renewed bombing Ukraine early Friday, with central Kyiv rocked by explosions. Investors are pondering how the fighting, its effect on commodity markets and retaliatory Western sanctions will ripple through a world economy already grappling with elevated inflation and coming interest-rate rises by major central banks.The U.S. and its allies have laid out stiff restrictions on Russian companies and their ability to interact with the international financial system. The European Union will formally sign off on sanctions Friday that willc ut 70% of Russia’s banking system off from international financial markets. Officials in Ukraine, the Baltics and the U.K. are calling for the sanctions to go further, cutting Russia off completely from infrastructure that ties together banks around the world.Investors are pondering how sanctions will affect the global economy.“I do not think that this highly volatile period is already coming to an end,” said Daniel Egger, chief investment officer at St. Gotthard Fund Management. “Right now we have to focus now on what’s happening in Kyiv, how bloody the coming days will be, and I would say definitely the Russian sanctions still can be stepped up.”In bond markets, yields fell in a sign investors still sought the safety of safe-haven assets. The yield on the benchmark U.S. 10-year Treasury note declined to 1.949% from 1.969% Thursday. Yields and prices move inversely. Gold prices, however, slipped 0.7% to $1,914 a troy ounce.Among individual European stocks, some companies that were hammered at the start of Russia’s attack clawed back some lost ground. Russian gold producer Polymetal International rose 14%. Hungarian budget airline Wizz Air rose 4.9%. But banks with exposure to Russia or commodity markets came under pressure, including ING Groep,Société Générale and UniCredit. Shares of British arms and aerospace company BAE Systems, which has gained on the prospect of higher defense spending, added a further 4.3%.“It looks like the military action in Ukraine could be protracted,” said Yung-Yu Ma, chief investment strategist for BMO Wealth Management in the U.S. In this case, short-term market movement is difficult to predict, he said.Rapid inflation and the prospect of tighter monetary policy were complicating the outlook for some traditional safe-haven assets such as Treasury bonds, the U.S. dollar and gold, Mr. Ma added.","news_type":1,"symbols_score_info":{".DJI":0.9,"YMmain":0.9,"ESmain":0.9,".IXIC":0.9,".SPX":0.9,"NQmain":0.9}},"isVote":1,"tweetType":1,"viewCount":2437,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004297598,"gmtCreate":1642605034120,"gmtModify":1676533726958,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004297598","repostId":"2204307707","repostType":4,"repost":{"id":"2204307707","kind":"highlight","pubTimestamp":1642597998,"share":"https://ttm.financial/m/news/2204307707?lang=en_US&edition=fundamental","pubTime":"2022-01-19 21:13","market":"us","language":"en","title":"3 Unstoppable Growth Stocks to Buy If There's a Stock Market Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2204307707","media":"Motley Fool","summary":"These three top growth names are already down a lot and trade at fair prices, but could become really huge bargains if the market falls more amid rising interest rates.","content":"<div>\n<p>Amid fears over interest rate hikes, many top growth stocks are down 20%, 40%, or even 60% or more from their all-time highs in a relatively short amount of time. Higher inflation and interest rates ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/18/3-unstoppable-growth-stocks-to-buy-if-theres-a-sto/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Unstoppable Growth Stocks to Buy If There's a Stock Market Sell-Off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Unstoppable Growth Stocks to Buy If There's a Stock Market Sell-Off\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 21:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/18/3-unstoppable-growth-stocks-to-buy-if-theres-a-sto/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amid fears over interest rate hikes, many top growth stocks are down 20%, 40%, or even 60% or more from their all-time highs in a relatively short amount of time. Higher inflation and interest rates ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/18/3-unstoppable-growth-stocks-to-buy-if-theres-a-sto/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4559":"巴菲特持仓","BK4566":"资本集团","SE":"Sea Ltd","BK4551":"寇图资本持仓","CRWD":"CrowdStrike Holdings, Inc.","BK4528":"SaaS概念","BK4532":"文艺复兴科技持仓","STNE":"StoneCo","BK4097":"系统软件","BK4548":"巴美列捷福持仓","BK4535":"淡马锡持仓","BK4106":"数据处理与外包服务","BK4503":"景林资产持仓","BK4554":"元宇宙及AR概念","BK4560":"网络安全概念","BK4085":"互动家庭娱乐"},"source_url":"https://www.fool.com/investing/2022/01/18/3-unstoppable-growth-stocks-to-buy-if-theres-a-sto/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204307707","content_text":"Amid fears over interest rate hikes, many top growth stocks are down 20%, 40%, or even 60% or more from their all-time highs in a relatively short amount of time. Higher inflation and interest rates could hurt the present value of future earnings, causing many high-multiple stocks to sell off.To be fair, after stratospheric runs through the pandemic, a lot of top growth names had gotten ahead of themselves, so the declines have seemed reasonable. However, some best-in-class growth stocks have now been thoroughly discounted. If the pain continues, these top names would become absolute bargains for the forward-thinking investor.Image source: Getty Images.1. Sea LimitedShares of Southeast Asian mobile gaming, e-commerce, and digital finance company Sea Limited (NYSE:SE) have been more than cut in half in just two months. Sure, the company reported slowing sequential growth in its profitable digital entertainment segment last quarter, which is heavily influenced by the four-year-old gaming hit Free Fire. However, it was somewhat inevitable that mobile-gaming growth might soften, as the third quarter marked the first summer since vaccines were widely available.Meanwhile, Sea's highest-growth businesses, including its Shopee e-commerce platform and SeaMoney digital finance ecosystem, showed strong growth. E-commerce revenue rocketed 134% last quarter, and SeaMoney surged more than 800%, albeit off a small base.Yes, Chinese internet giant Tencent did just sell some of its Sea Limited stake, which could shake others' confidence in the company. But Tencent really just sold off a small portion of its holdings, decreasing its economic interest in Sea from 21.3% to 18.7%. That's just a 12% trimming of its position. In addition, Tencent is converting super-voting shares to regular shares, so its voting power will go under 10%.The move might actually be due to the fact that Sea is rapidly expanding around the world, entering the huge markets of India and Europe last year. Likely, customers and authorities in those countries wouldn't want a company overly influenced by China to be too successful or retain too much consumer data. So the divestiture and reduction in Tencent's voting share could have been necessary for Sea to succeed in its next wave of growth.After Sea's rapid correction, its stock trades for just eight times revenue. And while the company is burning through cash, it still has about $7 billion in net cash on its balance sheet, and it grew revenue by more than 120% last quarter. It's hard to say when these types of stocks will bottom, but Sea is still executing quite well, and its growth path is long.2. CrowdStrikeAlthough it's already 40% off its highs, CrowdStrike Holdings (NASDAQ:CRWD) still trades at an expensive-looking 34 times sales, so it could very well sell off further.But it also might not. CrowdStrike is a best-in-class cloud security company that can justify its high valuation. Not only is its patented Falcon agent and Threat Graph architecture taking market share from legacy cyber players, but the overall cybersecurity market itself also should grow at double-digit rates for the next decade, especially in the cloud, where CrowdStrike excels.The company grew annualized recurring revenue by 67% last quarter, and added customers at an even higher 75% clip, with a net retention rate of 125%. But it isn't resting on those laurels, as it's still investing heavily, both internally and through acquisitions, to expand its offerings from endpoint security to an entire comprehensive cybersecurity platform.The company sees its total addressable market growing to $55 billion next year, up from $25 billion at its initial public offering, and growing to a potential $116 billion by 2025 as enterprises are forced to invest more in cloud-based security amid rising threats.What I like most about CrowdStrike is the network effect of its platform, which uses a combination of artificial intelligence and centralization that enables its Threat Graph to become smarter the more clients it gets. With that compounding advantage and huge growth opportunity, the stock is a definite buy target amid any further sell-off.3. StoneCoBrazilian payments company StoneCo (NASDAQ:STNE) is down nearly 80% over the past year and carries a market cap of just $5 billion today, so it might be hard to see how it falls further. But of course, anything is possible.StoneCo's stock has been decimated amid high inflation and surging interest rates in Brazil. While its payment processing business shouldn't be too affected, since it takes a fixed percentage of every transaction that goes through its merchant customers, other elements of its business have been negatively affected.Mainly, StoneCo had been ramping up its merchant lending in the third quarter just as interest rates have spiked, which could be a problem. Brazil's economic picture has deteriorated somewhat, which is not exactly the type of environment in which you want to make more loans. In addition, StoneCo has to borrow on its own lines of credit to fund the loans, but it has been reluctant to raise rates on customers as rapidly as its own interest costs have gone up.  So margins in its credit business have come down.At the same time, StoneCo is also doubling down on certain growth initiatives. Management wants the company to branch out from its core high-margin payments processing business to become a comprehensive digital open-banking solution across enterprise resource planning, order management software, insurance, and other digital banking products.These growth initiatives could make StoneCo a much bigger business in the long run, but it's requiring investment now. So the company's high 30.8% adjusted net income margin in the third quarter of 2020 plummeted to just a 9% net profit margin last quarter, with adjusted net profits falling 53.9% over the prior year.While that drop looks scary, revenue did also surge 57.3% as management refocuses on growth over profits right now, coming out of the pandemic. If its initiatives work out, and if Brazil's economy doesn't deteriorate too much, margins should rise again and the stock could bounce back in a big way. So investors should definitely look to this high-risk, high-reward growth stock amid any further sell-off.","news_type":1,"symbols_score_info":{"STNE":1,"CRWD":1,"SE":1}},"isVote":1,"tweetType":1,"viewCount":2558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004657243,"gmtCreate":1642596304461,"gmtModify":1676533725780,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Insightful !","listText":"Insightful !","text":"Insightful !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004657243","repostId":"2204081628","repostType":4,"repost":{"id":"2204081628","kind":"highlight","pubTimestamp":1642580000,"share":"https://ttm.financial/m/news/2204081628?lang=en_US&edition=fundamental","pubTime":"2022-01-19 16:13","market":"us","language":"en","title":"Intel stock has a bright near-term future, says analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2204081628","media":"MarketWatch","summary":"Despite lingering long-term challenges, Intel could deliver a positive earnings surprise, analyst sa","content":"<html><head></head><body><p>Despite lingering long-term challenges, Intel could deliver a positive earnings surprise, analyst says</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/713259c13e9147c20cad50a5f5eed047\" tg-width=\"1050\" tg-height=\"699\" width=\"100%\" height=\"auto\"/><span>Intel shares could perform well ahead of the company’s February investor event, says an analyst.</span></p><p>Intel Corp. shares may have some bright spots ahead--at least in the very near future.</p><p>Citi Research analyst Christopher Danely likes the setup for the chipmaker&#39;s stock in the weeks to come, given the potential for a positive earnings surprise and optimism heading into the company&#39;s February investor day.</p><p>While Danely still has a neutral rating on Intel&#39;s shares, he added a &#34;positive Catalyst Watch&#34; designation to the name on Tuesday, which he said reflects expectations for near-term upside.</p><p>Danely thinks that demand for personal computers has been &#34;well above expectations&#34; given the &#34;resurgent enterprise refresh.&#34; That trend could help Intel positively surprise with its fourth-quarter results and first-quarter outlook, he reasoned. The company is due to report results after the closing bell on Wednesday, Jan. 26.</p><p>Further, he anticipates that Intel&#39;s stock will &#34;trade well ahead of its investor meeting, scheduled for Feb. 17.</p><p>Beyond that, he sees some longer-term challenges in store for Intel. For one, he argued that &#34;considerable effort and focus still will be needed by Intel, especially in manufacturing, to catch up to its competitors.&#34; Danely also thinks that PC demand will &#34;revert to the mean given two straight years of double digit growth.&#34;</p><p>Shares of Intel fell 1.7% on Tuesday. They&#39;ve gained 1.3% over the past three months as the Dow Jones Industrial Average has risen 0.4%.</p></body></html>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel stock has a bright near-term future, says analyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel stock has a bright near-term future, says analyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 16:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/intel-stock-has-a-bright-near-term-future-says-analyst-11642535769?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite lingering long-term challenges, Intel could deliver a positive earnings surprise, analyst saysIntel shares could perform well ahead of the company’s February investor event, says an analyst....</p>\n\n<a href=\"https://www.marketwatch.com/story/intel-stock-has-a-bright-near-term-future-says-analyst-11642535769?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4141":"半导体产品","INTC":"英特尔","BK4535":"淡马锡持仓","BK4554":"元宇宙及AR概念","BK4515":"5G概念","BK4512":"苹果概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4527":"明星科技股","BK4529":"IDC概念","BK4550":"红杉资本持仓"},"source_url":"https://www.marketwatch.com/story/intel-stock-has-a-bright-near-term-future-says-analyst-11642535769?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204081628","content_text":"Despite lingering long-term challenges, Intel could deliver a positive earnings surprise, analyst saysIntel shares could perform well ahead of the company’s February investor event, says an analyst.Intel Corp. shares may have some bright spots ahead--at least in the very near future.Citi Research analyst Christopher Danely likes the setup for the chipmaker's stock in the weeks to come, given the potential for a positive earnings surprise and optimism heading into the company's February investor day.While Danely still has a neutral rating on Intel's shares, he added a \"positive Catalyst Watch\" designation to the name on Tuesday, which he said reflects expectations for near-term upside.Danely thinks that demand for personal computers has been \"well above expectations\" given the \"resurgent enterprise refresh.\" That trend could help Intel positively surprise with its fourth-quarter results and first-quarter outlook, he reasoned. The company is due to report results after the closing bell on Wednesday, Jan. 26.Further, he anticipates that Intel's stock will \"trade well ahead of its investor meeting, scheduled for Feb. 17.Beyond that, he sees some longer-term challenges in store for Intel. For one, he argued that \"considerable effort and focus still will be needed by Intel, especially in manufacturing, to catch up to its competitors.\" Danely also thinks that PC demand will \"revert to the mean given two straight years of double digit growth.\"Shares of Intel fell 1.7% on Tuesday. They've gained 1.3% over the past three months as the Dow Jones Industrial Average has risen 0.4%.","news_type":1,"symbols_score_info":{"INTC":1}},"isVote":1,"tweetType":1,"viewCount":3087,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006194130,"gmtCreate":1641628947957,"gmtModify":1676533636092,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Great to learn about&nbsp;Vir Biotech….","listText":"Great to learn about&nbsp;Vir Biotech….","text":"Great to learn about Vir Biotech….","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006194130","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://ttm.financial/m/news/1134509683?lang=en_US&edition=fundamental","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<html><head></head><body><p>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><b>A safe harbor in stormy weather</b></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><b>The antibody market all to itself</b></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-08 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"VIR":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3035,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9008258351,"gmtCreate":1641467616308,"gmtModify":1676533618062,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Another company added to watchlist!!!!","listText":"Another company added to watchlist!!!!","text":"Another company added to watchlist!!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008258351","repostId":"1116653019","repostType":4,"repost":{"id":"1116653019","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641460234,"share":"https://ttm.financial/m/news/1116653019?lang=en_US&edition=fundamental","pubTime":"2022-01-06 17:10","market":"us","language":"en","title":"Alterity Therapeutics Soared Over 36% in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1116653019","media":"Tiger Newspress","summary":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a","content":"<html><head></head><body><p>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alterity Therapeutics Soared Over 36% in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlterity Therapeutics Soared Over 36% in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-06 17:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Alterity Therapeutics soared over 36% in premarket trading.<img src=\"https://static.tigerbbs.com/4e761b186bdb71cae54640b4ab798107\" tg-width=\"768\" tg-height=\"560\" width=\"100%\" height=\"auto\"/>Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson&#39;s and Alzheimer&#39;s diseases.</p><p>The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATHE":"Alterity Therapeutics Limited"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116653019","content_text":"Alterity Therapeutics soared over 36% in premarket trading.Alterity Therapeutics (ASX:ATH) secured a US patent for compounds to treat neurodegenerative diseases, including Parkinson's and Alzheimer's diseases.The patent covers more than 80 compounds and secures exclusivity for a new class of iron chaperones, which would redistribute excess iron implicated in many neurodegenerative diseases, according to a Thursday news release.","news_type":1,"symbols_score_info":{"ATHE":0.9}},"isVote":1,"tweetType":1,"viewCount":3175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003950712,"gmtCreate":1640858492350,"gmtModify":1676533548443,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Good to know&nbsp;","listText":"Good to know&nbsp;","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003950712","repostId":"1180506204","repostType":4,"repost":{"id":"1180506204","kind":"news","pubTimestamp":1640852448,"share":"https://ttm.financial/m/news/1180506204?lang=en_US&edition=fundamental","pubTime":"2021-12-30 16:20","market":"us","language":"en","title":"Two Doses of J&J’s Vaccine Slashes Omicron Hospital Stays","url":"https://stock-news.laohu8.com/highlight/detail?id=1180506204","media":"Bloomberg","summary":"Booster shot following the one-dose vaccine cut severe diseaseStudy findings offer hope as omicron c","content":"<div>\n<p>Booster shot following the one-dose vaccine cut severe diseaseStudy findings offer hope as omicron cases soar worldwideA health worker prepares doses of the Johnson & Johnson Covid-19 vaccine in Cape ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-30/two-doses-of-j-j-s-vaccine-slashed-omicron-hospital-stays\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Two Doses of J&J’s Vaccine Slashes Omicron Hospital Stays</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwo Doses of J&J’s Vaccine Slashes Omicron Hospital Stays\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 16:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-30/two-doses-of-j-j-s-vaccine-slashed-omicron-hospital-stays><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Booster shot following the one-dose vaccine cut severe diseaseStudy findings offer hope as omicron cases soar worldwideA health worker prepares doses of the Johnson & Johnson Covid-19 vaccine in Cape ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-30/two-doses-of-j-j-s-vaccine-slashed-omicron-hospital-stays\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-30/two-doses-of-j-j-s-vaccine-slashed-omicron-hospital-stays","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180506204","content_text":"Booster shot following the one-dose vaccine cut severe diseaseStudy findings offer hope as omicron cases soar worldwideA health worker prepares doses of the Johnson & Johnson Covid-19 vaccine in Cape Town, South Africa. Photographer: Dwayne Senior/BloombergTwo doses of Johnson & Johnson’s Covid-19 vaccine slashed hospitalizations caused by the omicron variant in South Africa by up to 85%, a critical finding since the shot is being increasingly relied upon across the continent, researchers said.The results are a welcome bit of news as the explosive rise of omicron pushes the world to a record number of daily cases, and evidence emerges that the highly mutated strain can evade the protection that normally stems from vaccination. They also could help explain why hospitalizations and deaths aren’t following the exponential growth in new cases.Visitors queue for vaccines at the Discovery Ltd. mass Covid-19 vaccination site in Johannesburg, South Africa, on Thursday, Dec. 9, 2021.Photographer: Waldo Swiegers/BloombergThe study from the South African Medical Research Council found that protection levels rose in the weeks and months after a booster dose was given to those who previously received the J&J vaccine. It prevented 85% of hospitalizations one to two months after the second shot was given, up from 63% for people who received the booster within the past two weeks.“The results are important and reassuring,” said Glenda Gray, the lead researcher and president of the South African Medical Research Council. The study, one of the largest of its kind in the world, “shows at a global level that this regimen can be useful,” Gray said in a telephone interview.Almost half a million South African health workers were given J&J vaccines as part of a major trial ahead of the country’s general rollout earlier this year. They were offered boosters of the same single-shot dose starting in November, paving the way for this research.Dominant StrainThe researchers tracked hospitalizations that occurred from Nov. 8 through Dec. 17 in South Africa, when omicron quickly became the dominant strain circulating in the nation. They compared the records of 69,092 health care workers who got the J&J vaccine to a matched group of unvaccinated individuals who were enrolled in the same managed care organization.There were 713 hospital admissions among those who were unvaccinated, compared to 10 for those who got the booster within two weeks, 8 for those who got it two weeks to a month earlier, and three among those who got it more than a month prior.The results are the first evidence that a second dose of the J&J shot given six to nine months after an initial injection is effective against severe infection caused by omicron, the investigators said in the study, posted on medRxiv.org.Johnson & Johnson shipped globally more than 200 million doses of its vaccine as of mid-December, making it the seventh-biggest shot in the world, according to health analytics company Airfinity.The study was funded by the government as well as donors including the Solidarity Response Fund NPC, The Michael & Susan Dell Foundation, The Elma Vaccines and Immunization Foundation and the Bill & Melinda Gates Foundation.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":2551,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009884272,"gmtCreate":1640612649275,"gmtModify":1676533528965,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"To the 🌙 pls!!!","listText":"To the 🌙 pls!!!","text":"To the 🌙 pls!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009884272","repostId":"1168370421","repostType":4,"repost":{"id":"1168370421","kind":"news","pubTimestamp":1640607614,"share":"https://ttm.financial/m/news/1168370421?lang=en_US&edition=fundamental","pubTime":"2021-12-27 20:20","market":"us","language":"en","title":"Micron Technology: Expect More Of These Rallies","url":"https://stock-news.laohu8.com/highlight/detail?id=1168370421","media":"Seeking Alpha","summary":"Summary\n\nMicron Technology stock recently rallied 10.5% in a single day.\nThe rally was probably due ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Micron Technology stock recently rallied 10.5% in a single day.</li>\n <li>The rally was probably due to a stellar earnings release the company put out the day before.</li>\n <li>Most likely, Micron will see continued upside, as demand for its products is only growing.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b3cccfdfe04ca23523841d6775bbb072\" tg-width=\"1536\" tg-height=\"1075\" width=\"100%\" height=\"auto\"><span>Georgijevic/E+ via Getty Images</span></p>\n<p><b>Micron Technology</b>(MU) stock went on a pronounced rally Tuesday, rising 10.5% in a single trading day. It rallied another 5% on Thursday, leading to 15.66% gains for the week. The rally came immediately after a strong earnings release that beat on both revenue and profit. For the quarter, revenue came in at $7.69 billion (beat by $10 million) and EPS came in at $2.16 (beat by $0.02). The growth in EPS was impressive because it showed that the previous quarter’s stunning growth was no fluke.</p>\n<p>For the&nbsp;fourth quarter, Micron grew revenue by 37% and earnings by 175% year-over-year. It was an incredible achievement, one that few saw the company replicating. Fortunately, it did, with very similar results for the first quarter of fiscal 2022. Micron’s first quarter revenue growth was nearly as strong as its fourth quarter growth, and its earnings growth was actually slightly better, coming in at a whopping 177%.</p>\n<p>Clearly, Micron has put a couple of great quarters behind it. Both the fourth and first quarters saw triple-digit growth in earnings, and the outlook was strong as well. The company forecast 20% growth in DRAM demand and 30% growth in demand for NAND. It expected its shipment growth for each category to be in-line with industry growth. It follows from this that Micron expects revenue growth between 20% and 30% assuming no price increases.</p>\n<p>It’s a pretty rosy picture. And some investors believe that this is only the beginning. Legendary value investors like Li Lu and Mohnish Pabrai are betting heavily on Micron, believing that the memory sector is undervalued. Indeed, it is, if Micron is any indication. The stock trades at just 12 times earnings even after Tuesday’s monster rally. By the standards of tech stocks, it’s super cheap. And it’s one of the few ways you can get exposure to the memory industry on its own, with no other tech stuff packaged in.<b>Samsung</b>(OTC:SSNLF) is the biggest memory player, but it’s not a pure play. SK Hynix (OTC:HXSCF) is a pure play and has&nbsp;multiples similar to Micron’s, with&nbsp;similar growth as well. That leaves us with basically two pure play memory stocks to choose from. And they’re both very cheap. So if you’re looking for dirt-cheap tech plays, memory is where you want to be.</p>\n<p>Micron is well positioned in the memory industry. It proved its mettle by withstanding the loss of Huawei’s business after the U.S. banned chip exports to China, coming back from the ordeal with a strong balance sheet. After seeing its&nbsp;revenue dip 8% in 2020,Micron is back to strong year-over-year growth, not only compared to 2020 but compared to 2019 as well. It looks like everything is full steam ahead for Micron. Accordingly I will develop a bullish thesis on the stock in this article, arguing that its unique mix of growth and value characteristics makes it a worthy buy.</p>\n<p><b>Memory Industry Factors</b></p>\n<p>Before looking at MU’s own fundamentals we need to look at the industry the company operates in. Micron forecasts that its growth will follow industry trends, so we need to know what the memory industry looks like.</p>\n<p>The DRAM industry is basically an oligopoly between Micron, Samsung and SK Hynix. According to&nbsp;Statista, Samsung leads with 42%, SK Hynix is in second with 29%, and Micron is in third with 23%. There are other players but their market share is too small to be worth mentioning, the largest of them having 3.3%. The picture is a little different for NAND flash storage, with&nbsp;more major players, but Micron has a healthy 10% share there, too.</p>\n<p>So, Micron is a top player in the memory industry. It’s not #1, but it is one of the top two pure plays in the space. Its strong position in the industry isn’t disputed. The question is whether the industry’s own prospects are strong.</p>\n<p>Micron, unsurprisingly, thinks that they are. In addition to forecasting 20%-30% growth in its verticals, the company also expects long-term CAGR growth ranging from the mid-teens to 30%. That would be great news if it materialized. With that said, you’d expect a company to say that its industry is strong. So we might want to look at some third-party opinions here.</p>\n<p>The market research firm Verified Market Research&nbsp;expects the DRAM industry to grow at 8.7%. This is a little over half Micron’s internal forecast for DRAM demand. At 8.7% CAGR growth Micron would be growing slower than it is now, although that isn’t bad growth for a stock with a P/E of 11. Many bank stocks are more expensive than that and 8.7% revenue growth is a banner year for a bank.</p>\n<p>As for NAND, I was able to find forecasts anywhere from 11% CAGR (Mordor Intelligence) to 22% (Valuates Reports). Again these don’t match Micron’s rosy forecasts, but are pretty optimistic themselves. Barely anybody is expecting the memory industry to decline, and most organizations are forecasting double digit growth. This makes sense when you consider who these companies serve. In addition to producing sticks of RAM and SD cards/personal SSDs for consumers, they also produce:</p>\n<ul>\n <li><p>RAM for 5G smartphones.</p></li>\n <li><p>SSDs for data centers.</p></li>\n <li><p>Components for computer manufacturers.</p></li>\n</ul>\n<p>These are all strong growth sectors. Smartphone growth didslow down a bit from 2018 to 2020, but picked up again in 2021. Cloud computing is currently a huge growth driver for pretty much all of the companies in the space.<b>Amazon</b>(AMZN),<b>Microsoft</b>(MSFT) and&nbsp;<b>Alphabet</b>(GOOG) (GOOGL) are all seeing&nbsp;high double-digit growth in their cloud businesses. Companies like&nbsp;<b>Meta Platforms</b>(FB), which don’t operate cloud businesses, nevertheless rely heavily on data centers to run their own services. So there is massive and growing demand for DRAM and NAND from internet companies.</p>\n<p>What all this means is that powerful industry forces are driving the increase in demand for memory. It’s not just that the industry itself is growing, but the much larger industries it sells to are growing. This means there’s a basis for thinking that the memory industry’s strong growth will continue. As long as smartphones remain popular and data centers remain necessary, there’ll be a need for memory. And Micron is one of the three leading companies supplying it.</p>\n<p><b>Financials and Valuation</b></p>\n<p>Having looked at Micron’s industry position, we can now turn to its financials and valuation.</p>\n<p>Micron Technology is, broadly, a highly profitable, fast-growing business with an attractive valuation. It’s one of the few stocks I’ve come across that scores ‘A’ or higher on four of Seeking Alpha Quant’s factors (growth, profitability, momentum and valuation), and a quick glance at the company’s financials shows why that’s the case.</p>\n<p>First, let’s look at earnings for the most recent quarter. In the first quarter, Micron delivered:</p>\n<ul>\n <li><p>$7.68 billion in revenue, up 33% year over year (but down 7% sequentially).</p></li>\n <li><p>$2.6 billion in operating income, up 203% year-over-year.</p></li>\n <li><p>Net income: $2.3 billion, up 176% year-over-year.</p></li>\n <li><p>Diluted EPS: $2.16, up 176% year-over-year.</p></li>\n <li><p>Cash from operations: $3.9 billion, up 100% year-over-year.</p></li>\n</ul>\n<p>These were pretty solid results. Not only was the growth strong, the profitability was strong as well. $2.6 billion in earnings on $7.6 billion in revenue gives us a 33% net margin. Extremely high. The company had $45 billion in equity for the period. That produces a somewhat unimpressive return on equity of 5.77%, althoughSeeking Alpha Quantshows a healthy 17% ROE for the full trailing 12 month period. So we’ve got decent earnings and profitability in the most recent period.</p>\n<p>The same holds true for the last five years as well. For the past five years, MU’s CAGR growth rates in select metrics have been:</p>\n<ul>\n <li><p>18% in revenue.</p></li>\n <li><p>90% in operating income.</p></li>\n <li><p>118% in ROE.</p></li>\n</ul>\n<p>Unfortunately we can’t do the five-year CAGR calculation for net income or EPS because those figures were&nbsp;negative in 2016. However, if we start from 2015 and do a six year CAGR calculation, we get 16% six-year CAGR growth in EPS. Not quite as strong as the most recent quarter, but still very strong.</p>\n<p>So we’ve got very strong financials and growth from Micron. One strike the company has against it is earnings volatility. As you’ll note from above, earnings were negative in 2016. Also, they hit a peak in 2018 and then declined in 2019 and again in 2020–mostly due to the loss of Huawei. This is all reflected in the stock’s price history: it’s&nbsp;more volatile than average, with a 1.15 beta coefficient. Put simply, the stock isn’t for the faint of heart. Micron’s earnings have swung up and down dramatically throughout its history and that isn’t stopping any time soon. RAM prices arevery volatile, subject to massive booms and bust. This is part of RAM’s&nbsp;status as a commodity: companies buy it up in bulk from all suppliers and often stop buying when they have too much. This leads prices to go up and down as orders abruptly start and stop. Much like oil or coal, companies are sometimes just sitting on too much RAM to buy more.</p>\n<p>With all that said, these factors are well priced into Micron’s stock. At today’s prices, Micron trades at 12 times adjusted earnings, 14.6 times GAAP earnings, 3.57 times sales, 2.3 times book value and 7.3 times operating cash flow. These are basically dirt cheap multiples for a high-growth tech stock. And while a company like Micron can’t count on steadily climbing earnings that never dip, it should keep delivering more value to shareholders as demand for phones, data centers and laptops grows.</p>\n<p><b>The Bottom Line</b></p>\n<p>Micron Technology’s 15.6% one-week rally was no fluke. It was the expected result of a cheap stock well positioned to profit off of current tech trends, beating on earnings while having low multiples. As of December 2021, demand for DRAM and NAND flash is expected to keep growing. Whether Micron’s internal 20%-30% forecast will be hit remains to be seen, but even more modest forecasts call for growth in the 10%+ range. So, Micron’s business should continue to grow from here. Earnings growth will of course slow from the recent 175%, but it should remain strong for at least a few years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Micron Technology: Expect More Of These Rallies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicron Technology: Expect More Of These Rallies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 20:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4476781-micron-technology-expect-more-of-these-rallies><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nMicron Technology stock recently rallied 10.5% in a single day.\nThe rally was probably due to a stellar earnings release the company put out the day before.\nMost likely, Micron will see ...</p>\n\n<a href=\"https://seekingalpha.com/article/4476781-micron-technology-expect-more-of-these-rallies\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MU":"美光科技"},"source_url":"https://seekingalpha.com/article/4476781-micron-technology-expect-more-of-these-rallies","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168370421","content_text":"Summary\n\nMicron Technology stock recently rallied 10.5% in a single day.\nThe rally was probably due to a stellar earnings release the company put out the day before.\nMost likely, Micron will see continued upside, as demand for its products is only growing.\n\nGeorgijevic/E+ via Getty Images\nMicron Technology(MU) stock went on a pronounced rally Tuesday, rising 10.5% in a single trading day. It rallied another 5% on Thursday, leading to 15.66% gains for the week. The rally came immediately after a strong earnings release that beat on both revenue and profit. For the quarter, revenue came in at $7.69 billion (beat by $10 million) and EPS came in at $2.16 (beat by $0.02). The growth in EPS was impressive because it showed that the previous quarter’s stunning growth was no fluke.\nFor the fourth quarter, Micron grew revenue by 37% and earnings by 175% year-over-year. It was an incredible achievement, one that few saw the company replicating. Fortunately, it did, with very similar results for the first quarter of fiscal 2022. Micron’s first quarter revenue growth was nearly as strong as its fourth quarter growth, and its earnings growth was actually slightly better, coming in at a whopping 177%.\nClearly, Micron has put a couple of great quarters behind it. Both the fourth and first quarters saw triple-digit growth in earnings, and the outlook was strong as well. The company forecast 20% growth in DRAM demand and 30% growth in demand for NAND. It expected its shipment growth for each category to be in-line with industry growth. It follows from this that Micron expects revenue growth between 20% and 30% assuming no price increases.\nIt’s a pretty rosy picture. And some investors believe that this is only the beginning. Legendary value investors like Li Lu and Mohnish Pabrai are betting heavily on Micron, believing that the memory sector is undervalued. Indeed, it is, if Micron is any indication. The stock trades at just 12 times earnings even after Tuesday’s monster rally. By the standards of tech stocks, it’s super cheap. And it’s one of the few ways you can get exposure to the memory industry on its own, with no other tech stuff packaged in.Samsung(OTC:SSNLF) is the biggest memory player, but it’s not a pure play. SK Hynix (OTC:HXSCF) is a pure play and has multiples similar to Micron’s, with similar growth as well. That leaves us with basically two pure play memory stocks to choose from. And they’re both very cheap. So if you’re looking for dirt-cheap tech plays, memory is where you want to be.\nMicron is well positioned in the memory industry. It proved its mettle by withstanding the loss of Huawei’s business after the U.S. banned chip exports to China, coming back from the ordeal with a strong balance sheet. After seeing its revenue dip 8% in 2020,Micron is back to strong year-over-year growth, not only compared to 2020 but compared to 2019 as well. It looks like everything is full steam ahead for Micron. Accordingly I will develop a bullish thesis on the stock in this article, arguing that its unique mix of growth and value characteristics makes it a worthy buy.\nMemory Industry Factors\nBefore looking at MU’s own fundamentals we need to look at the industry the company operates in. Micron forecasts that its growth will follow industry trends, so we need to know what the memory industry looks like.\nThe DRAM industry is basically an oligopoly between Micron, Samsung and SK Hynix. According to Statista, Samsung leads with 42%, SK Hynix is in second with 29%, and Micron is in third with 23%. There are other players but their market share is too small to be worth mentioning, the largest of them having 3.3%. The picture is a little different for NAND flash storage, with more major players, but Micron has a healthy 10% share there, too.\nSo, Micron is a top player in the memory industry. It’s not #1, but it is one of the top two pure plays in the space. Its strong position in the industry isn’t disputed. The question is whether the industry’s own prospects are strong.\nMicron, unsurprisingly, thinks that they are. In addition to forecasting 20%-30% growth in its verticals, the company also expects long-term CAGR growth ranging from the mid-teens to 30%. That would be great news if it materialized. With that said, you’d expect a company to say that its industry is strong. So we might want to look at some third-party opinions here.\nThe market research firm Verified Market Research expects the DRAM industry to grow at 8.7%. This is a little over half Micron’s internal forecast for DRAM demand. At 8.7% CAGR growth Micron would be growing slower than it is now, although that isn’t bad growth for a stock with a P/E of 11. Many bank stocks are more expensive than that and 8.7% revenue growth is a banner year for a bank.\nAs for NAND, I was able to find forecasts anywhere from 11% CAGR (Mordor Intelligence) to 22% (Valuates Reports). Again these don’t match Micron’s rosy forecasts, but are pretty optimistic themselves. Barely anybody is expecting the memory industry to decline, and most organizations are forecasting double digit growth. This makes sense when you consider who these companies serve. In addition to producing sticks of RAM and SD cards/personal SSDs for consumers, they also produce:\n\nRAM for 5G smartphones.\nSSDs for data centers.\nComponents for computer manufacturers.\n\nThese are all strong growth sectors. Smartphone growth didslow down a bit from 2018 to 2020, but picked up again in 2021. Cloud computing is currently a huge growth driver for pretty much all of the companies in the space.Amazon(AMZN),Microsoft(MSFT) and Alphabet(GOOG) (GOOGL) are all seeing high double-digit growth in their cloud businesses. Companies like Meta Platforms(FB), which don’t operate cloud businesses, nevertheless rely heavily on data centers to run their own services. So there is massive and growing demand for DRAM and NAND from internet companies.\nWhat all this means is that powerful industry forces are driving the increase in demand for memory. It’s not just that the industry itself is growing, but the much larger industries it sells to are growing. This means there’s a basis for thinking that the memory industry’s strong growth will continue. As long as smartphones remain popular and data centers remain necessary, there’ll be a need for memory. And Micron is one of the three leading companies supplying it.\nFinancials and Valuation\nHaving looked at Micron’s industry position, we can now turn to its financials and valuation.\nMicron Technology is, broadly, a highly profitable, fast-growing business with an attractive valuation. It’s one of the few stocks I’ve come across that scores ‘A’ or higher on four of Seeking Alpha Quant’s factors (growth, profitability, momentum and valuation), and a quick glance at the company’s financials shows why that’s the case.\nFirst, let’s look at earnings for the most recent quarter. In the first quarter, Micron delivered:\n\n$7.68 billion in revenue, up 33% year over year (but down 7% sequentially).\n$2.6 billion in operating income, up 203% year-over-year.\nNet income: $2.3 billion, up 176% year-over-year.\nDiluted EPS: $2.16, up 176% year-over-year.\nCash from operations: $3.9 billion, up 100% year-over-year.\n\nThese were pretty solid results. Not only was the growth strong, the profitability was strong as well. $2.6 billion in earnings on $7.6 billion in revenue gives us a 33% net margin. Extremely high. The company had $45 billion in equity for the period. That produces a somewhat unimpressive return on equity of 5.77%, althoughSeeking Alpha Quantshows a healthy 17% ROE for the full trailing 12 month period. So we’ve got decent earnings and profitability in the most recent period.\nThe same holds true for the last five years as well. For the past five years, MU’s CAGR growth rates in select metrics have been:\n\n18% in revenue.\n90% in operating income.\n118% in ROE.\n\nUnfortunately we can’t do the five-year CAGR calculation for net income or EPS because those figures were negative in 2016. However, if we start from 2015 and do a six year CAGR calculation, we get 16% six-year CAGR growth in EPS. Not quite as strong as the most recent quarter, but still very strong.\nSo we’ve got very strong financials and growth from Micron. One strike the company has against it is earnings volatility. As you’ll note from above, earnings were negative in 2016. Also, they hit a peak in 2018 and then declined in 2019 and again in 2020–mostly due to the loss of Huawei. This is all reflected in the stock’s price history: it’s more volatile than average, with a 1.15 beta coefficient. Put simply, the stock isn’t for the faint of heart. Micron’s earnings have swung up and down dramatically throughout its history and that isn’t stopping any time soon. RAM prices arevery volatile, subject to massive booms and bust. This is part of RAM’s status as a commodity: companies buy it up in bulk from all suppliers and often stop buying when they have too much. This leads prices to go up and down as orders abruptly start and stop. Much like oil or coal, companies are sometimes just sitting on too much RAM to buy more.\nWith all that said, these factors are well priced into Micron’s stock. At today’s prices, Micron trades at 12 times adjusted earnings, 14.6 times GAAP earnings, 3.57 times sales, 2.3 times book value and 7.3 times operating cash flow. These are basically dirt cheap multiples for a high-growth tech stock. And while a company like Micron can’t count on steadily climbing earnings that never dip, it should keep delivering more value to shareholders as demand for phones, data centers and laptops grows.\nThe Bottom Line\nMicron Technology’s 15.6% one-week rally was no fluke. It was the expected result of a cheap stock well positioned to profit off of current tech trends, beating on earnings while having low multiples. As of December 2021, demand for DRAM and NAND flash is expected to keep growing. Whether Micron’s internal 20%-30% forecast will be hit remains to be seen, but even more modest forecasts call for growth in the 10%+ range. So, Micron’s business should continue to grow from here. Earnings growth will of course slow from the recent 175%, but it should remain strong for at least a few years.","news_type":1,"symbols_score_info":{"MU":0.9}},"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863476770,"gmtCreate":1632424681890,"gmtModify":1676530778852,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Hanging by a thread ….","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Hanging by a thread ….","text":"$Alibaba(BABA)$Hanging by a thread ….","images":[{"img":"https://static.tigerbbs.com/cea02be4f5ae822eb07e0014244bfa0c","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863476770","isVote":1,"tweetType":1,"viewCount":1165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":863069611,"gmtCreate":1632338730133,"gmtModify":1676530755861,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>Finally a somewhat&nbsp;reassuring green comeback ….","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>Finally a somewhat&nbsp;reassuring green comeback ….","text":"$Micron Technology(MU)$Finally a somewhat reassuring green comeback ….","images":[{"img":"https://static.tigerbbs.com/94756d5951dd424d1f1156527a7fd11a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863069611","isVote":1,"tweetType":1,"viewCount":894,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":869925705,"gmtCreate":1632236902907,"gmtModify":1676530732139,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Will there be a rebound?","listText":"Will there be a rebound?","text":"Will there be a rebound?","images":[{"img":"https://static.tigerbbs.com/5572bb6735cb601e796a9b39f1e00a35","width":"750","height":"2380"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869925705","isVote":1,"tweetType":1,"viewCount":700,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":860199483,"gmtCreate":1632143638642,"gmtModify":1676530709446,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>A fresh start to the week…","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>A fresh start to the week…","text":"$Micron Technology(MU)$A fresh start to the week…","images":[{"img":"https://static.tigerbbs.com/5e0d34e6740bf4776ab402c889bc24ab","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860199483","isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":884119651,"gmtCreate":1631866621673,"gmtModify":1676530656437,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Let’s maintain the new momentum, Baba!","listText":"Let’s maintain the new momentum, Baba!","text":"Let’s maintain the new momentum, Baba!","images":[{"img":"https://static.tigerbbs.com/04c3d70117e082073ccf5f4bf2ade702","width":"750","height":"2389"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884119651","isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":885213294,"gmtCreate":1631796826118,"gmtModify":1676530637779,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Baba….you got this…come back to life please….","listText":"Baba….you got this…come back to life please….","text":"Baba….you got this…come back to life please….","images":[{"img":"https://static.tigerbbs.com/59f8b0edb5c1fb0c5da52c61dce4a99d","width":"750","height":"2443"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/885213294","isVote":1,"tweetType":1,"viewCount":569,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":882601603,"gmtCreate":1631680079702,"gmtModify":1676530607446,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>Slow and steady….","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>Slow and steady….","text":"$Micron Technology(MU)$Slow and steady….","images":[{"img":"https://static.tigerbbs.com/02f70f97aa6fdb855b755e4d2ff7c033","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882601603","isVote":1,"tweetType":1,"viewCount":844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":882603974,"gmtCreate":1631679878898,"gmtModify":1676530607371,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Trending up, I hope?","listText":"Trending up, I hope?","text":"Trending up, I hope?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882603974","isVote":1,"tweetType":1,"viewCount":1044,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882004927,"gmtCreate":1631629010369,"gmtModify":1676530594698,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Very unheard of list ….[Thinking]&nbsp;[Happy]&nbsp;","listText":"Very unheard of list ….[Thinking]&nbsp;[Happy]&nbsp;","text":"Very unheard of list ….[Thinking] [Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882004927","repostId":"2167553576","repostType":4,"isVote":1,"tweetType":1,"viewCount":817,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":122850891,"gmtCreate":1624612184313,"gmtModify":1703841706194,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/S51.SI\">$SEMBCORP MARINE LTD(S51.SI)$</a>Trying to average it out….hopefully things will get better","listText":"<a href=\"https://laohu8.com/S/S51.SI\">$SEMBCORP MARINE LTD(S51.SI)$</a>Trying to average it out….hopefully things will get better","text":"$SEMBCORP MARINE LTD(S51.SI)$Trying to average it out….hopefully things will get better","images":[{"img":"https://static.tigerbbs.com/8debc849ff8c1d2709155ae25aec1e9c","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":8,"repostSize":0,"link":"https://ttm.financial/post/122850891","isVote":1,"tweetType":1,"viewCount":1662,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3586170583260442","authorId":"3586170583260442","name":"tj1888","avatar":"https://static.tigerbbs.com/be489dd8feb1571d03f7d7bb02d2cb53","crmLevel":2,"crmLevelSwitch":0,"idStr":"3586170583260442","authorIdStr":"3586170583260442"},"content":"yes... i averaged down 6 times over a period of 5 years... had 20 lots before last year rights issue. regret my stupid decisions... lost over 30k in this counter...","text":"yes... i averaged down 6 times over a period of 5 years... had 20 lots before last year rights issue. regret my stupid decisions... lost over 30k in this counter...","html":"yes... i averaged down 6 times over a period of 5 years... had 20 lots before last year rights issue. regret my stupid decisions... lost over 30k in this counter..."},{"author":{"id":"3582004909535975","authorId":"3582004909535975","name":"Dabuelrxy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"idStr":"3582004909535975","authorIdStr":"3582004909535975"},"content":"If you're long term investor, average it out using rights issue, don't buy it from market now. If short term speculation, sell and look at other counters cos u likely lose more.","text":"If you're long term investor, average it out using rights issue, don't buy it from market now. If short term speculation, sell and look at other counters cos u likely lose more.","html":"If you're long term investor, average it out using rights issue, don't buy it from market now. If short term speculation, sell and look at other counters cos u likely lose more."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":895495229,"gmtCreate":1628763242761,"gmtModify":1676529846140,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Have not heard of these companies before…[Happy]&nbsp;","listText":"Have not heard of these companies before…[Happy]&nbsp;","text":"Have not heard of these companies before…[Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/895495229","repostId":"1126315062","repostType":4,"isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123260816,"gmtCreate":1624425018735,"gmtModify":1703836297960,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/S51.SI\">$SEMBCORP MARINE LTD(S51.SI)$</a>Is the change really gonna come this time?","listText":"<a href=\"https://laohu8.com/S/S51.SI\">$SEMBCORP MARINE LTD(S51.SI)$</a>Is the change really gonna come this time?","text":"$SEMBCORP MARINE LTD(S51.SI)$Is the change really gonna come this time?","images":[{"img":"https://static.tigerbbs.com/a0a5992377d1ab59d96800ce09591ee0","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/123260816","isVote":1,"tweetType":1,"viewCount":1063,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3550998686387787","authorId":"3550998686387787","name":"Soyabean89","avatar":"https://community-static.tradeup.com/news/eb77581e98e9ecdbe378a1373a31b0e9","crmLevel":12,"crmLevelSwitch":0,"idStr":"3550998686387787","authorIdStr":"3550998686387787"},"content":"Dun count it until the pandemic and travel restrictions eased","text":"Dun count it until the pandemic and travel restrictions eased","html":"Dun count it until the pandemic and travel restrictions eased"},{"author":{"id":"3575801325144625","authorId":"3575801325144625","name":"lcwy","avatar":"https://static.tigerbbs.com/05ab13caca6903ee9a9f63c270ea7364","crmLevel":1,"crmLevelSwitch":0,"idStr":"3575801325144625","authorIdStr":"3575801325144625"},"content":"That's what I said","text":"That's what I said","html":"That's what I said"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":179587596,"gmtCreate":1626564772815,"gmtModify":1703761671390,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Truly an important set of tips&nbsp;to all investors…having the cash&nbsp;to buy the dip is&nbsp;definitely key&nbsp;","listText":"Truly an important set of tips&nbsp;to all investors…having the cash&nbsp;to buy the dip is&nbsp;definitely key&nbsp;","text":"Truly an important set of tips to all investors…having the cash to buy the dip is definitely key","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/179587596","repostId":"2152899486","repostType":4,"isVote":1,"tweetType":1,"viewCount":939,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573703375513385","authorId":"3573703375513385","name":"JonLucky","avatar":"https://static.tigerbbs.com/15afb66e92e4e4d6d1a8e9b7854e9d5e","crmLevel":12,"crmLevelSwitch":1,"idStr":"3573703375513385","authorIdStr":"3573703375513385"},"content":"It often becomes a test of nerves and wisdom.","text":"It often becomes a test of nerves and wisdom.","html":"It often becomes a test of nerves and wisdom."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146971428,"gmtCreate":1626051749664,"gmtModify":1703752324682,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Bracing for the storm…","listText":"Bracing for the storm…","text":"Bracing for the storm…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/146971428","repostId":"1114863871","repostType":4,"repost":{"id":"1114863871","kind":"news","pubTimestamp":1626039626,"share":"https://ttm.financial/m/news/1114863871?lang=en_US&edition=fundamental","pubTime":"2021-07-12 05:40","market":"us","language":"en","title":"Chase, Delta, Goldman Sachs, PepsiCo, and Other Stocks to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1114863871","media":"Barron's","summary":"Second-quarter earnings season gets under way this week, with several big banks reporting. JPMorgan ChaseandGoldman SachsGroup kick things off on Tuesday, followed byBank of America,Wells Fargo,andCitigroupon Wednesday andMorgan Stanleyon Thursday.The week’s economic calendar will be equally busy. The Bureau of Labor Statistics releases the consumer price index for June on Tuesday, followed by the producer price index for June on Wednesday. Expectations are for year-over-year increases of 4.0% a","content":"<p>Second-quarter earnings season gets under way&nbsp;this week, with several big banks reporting.&nbsp;JPMorgan ChaseandGoldman SachsGroup kick things off on Tuesday, followed byBank of America,Wells Fargo,andCitigroupon Wednesday andMorgan Stanleyon Thursday.</p>\n<p>Other major companies reporting this week includePepsiCoandFastenalon Tuesday,Delta Air Lineson Wednesday,Taiwan Semiconductor ManufacturingandUnitedHealth Groupon Thursday, andKansas City Southernon Friday.</p>\n<p>The week’s economic calendar will be equally busy. The Bureau of Labor Statistics releases the consumer price index for June on Tuesday,&nbsp;followed by the producer price index for June on Wednesday. Expectations are for year-over-year increases of 4.0% and 6.4%, respectively, in the core CPI and core PPI.</p>\n<p>Investors and economists will also get a look at a pair of sentiment surveys this week:&nbsp;The National Federation of Independent Business’ Small Business Optimism Index for June on Tuesday and The University of Michigan’s Consumer Sentiment index for July on Friday. The&nbsp;Federal Reserve releases its latest beige book on Wednesday, the Census Bureau reports retail-sales data for June on Friday, and theBank of Japanannounces its latest monetary-policy decision on Friday.</p>\n<p><img src=\"https://static.tigerbbs.com/1508a89eaa3fb959feaaa832797a2c48\" tg-width=\"1176\" tg-height=\"360\"></p>\n<p><b>Monday 7/12</b></p>\n<p>FedExhosts a conference call to update the investment community on its business outlook.</p>\n<p><b>Tuesday 7/13</b></p>\n<p>JPMorgan Chase and Goldman Sachs Group kick off earnings season by reporting results before the market open. The two money-center banks recently lifted their dividends 11% and 60%, respectively.</p>\n<p>Conagra Brands,Fastenal,First Republic Bank,and PepsiCo report quarterly results.</p>\n<p>Dell Technologieshosts a conference call to discuss its ESG strategy.</p>\n<p><b>The Bureau of Labor</b>&nbsp;Statistics releases the consumer price index for June. Economists forecast a 4.9% year-over-year rise, after a 5% jump in May—the fastest rate of growth since August 2008. The core CPI, which excludes volatile food and energy prices, is expected to increase 4% compared with 3.8% previously.</p>\n<p><b>The National Federation</b>&nbsp;of Independent Business releases its Small Business Optimism Index for June. Consensus estimate is for a 99.5 reading, about even with the May figure.</p>\n<p><b>Wednesday 7/14</b></p>\n<p>Bank of America,BlackRock,Citigroup, Delta Air Lines,PNC Financial Services Group,and Wells Fargo release earnings.</p>\n<p><b>The Federal Reserve</b>&nbsp;releases the beige book for the fifth of eight times this year. The report gathers anecdotal evidence of current economic conditions in the 12 Federal Reserve districts.</p>\n<p><b>The BLS releases</b>&nbsp;the producer price index for June. Expectations are for both the PPI and core PPI to increase 0.5% month over month. This compares with gains of 0.8% and 0.7%, respectively, in May.</p>\n<p><b>Thursday 7/15</b></p>\n<p>Bank of New York Mellon,Cintas,Morgan Stanley, Taiwan Semiconductor Manufacturing,Truist Financial,U.S. Bancorp,and UnitedHealth Group hold conference calls to discuss quarterly results.</p>\n<p><b>Friday 7/16</b></p>\n<p>Charles Schwab,Ericsson,Kansas City Southern, andState Streetannounce earnings.</p>\n<p><b>The Bank of Japan</b>&nbsp;announces its monetary-policy decision. The central bank is widely expected to keep its key short-term interest rate unchanged at negative 0.1%. In June, the BOJ said it would launch a climate-change plan by the end of this year, and would release a preliminary plan at its July meeting. This could take the form of higher interest rates paid to banks for green-lending measures.</p>\n<p><b>The University of Michigan</b>&nbsp;releases its Consumer Sentiment index for July. Economists forecast an 86.5 reading, slightly higher than June’s 85.5. The index is still well below its levels from just prior to the pandemic.</p>\n<p><b>The Census Bureau</b>&nbsp;reports retail-sales data for June. Consensus estimate is for a 0.5% monthly decline in spending to $617 billion, after slumping 1.3% in May.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chase, Delta, Goldman Sachs, PepsiCo, and Other Stocks to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChase, Delta, Goldman Sachs, PepsiCo, and Other Stocks to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-12 05:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-for-investors-to-watch-this-week-51625883421><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Second-quarter earnings season gets under way this week, with several big banks reporting. JPMorgan ChaseandGoldman SachsGroup kick things off on Tuesday, followed byBank of America,Wells Fargo,...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-for-investors-to-watch-this-week-51625883421\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WFC":"富国银行","MS":"摩根士丹利","GS":"高盛","C":"花旗","TSM":"台积电","BAC":"美国银行","JPM":"摩根大通"},"source_url":"https://www.barrons.com/articles/stocks-for-investors-to-watch-this-week-51625883421","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114863871","content_text":"Second-quarter earnings season gets under way this week, with several big banks reporting. JPMorgan ChaseandGoldman SachsGroup kick things off on Tuesday, followed byBank of America,Wells Fargo,andCitigroupon Wednesday andMorgan Stanleyon Thursday.\nOther major companies reporting this week includePepsiCoandFastenalon Tuesday,Delta Air Lineson Wednesday,Taiwan Semiconductor ManufacturingandUnitedHealth Groupon Thursday, andKansas City Southernon Friday.\nThe week’s economic calendar will be equally busy. The Bureau of Labor Statistics releases the consumer price index for June on Tuesday, followed by the producer price index for June on Wednesday. Expectations are for year-over-year increases of 4.0% and 6.4%, respectively, in the core CPI and core PPI.\nInvestors and economists will also get a look at a pair of sentiment surveys this week: The National Federation of Independent Business’ Small Business Optimism Index for June on Tuesday and The University of Michigan’s Consumer Sentiment index for July on Friday. The Federal Reserve releases its latest beige book on Wednesday, the Census Bureau reports retail-sales data for June on Friday, and theBank of Japanannounces its latest monetary-policy decision on Friday.\n\nMonday 7/12\nFedExhosts a conference call to update the investment community on its business outlook.\nTuesday 7/13\nJPMorgan Chase and Goldman Sachs Group kick off earnings season by reporting results before the market open. The two money-center banks recently lifted their dividends 11% and 60%, respectively.\nConagra Brands,Fastenal,First Republic Bank,and PepsiCo report quarterly results.\nDell Technologieshosts a conference call to discuss its ESG strategy.\nThe Bureau of Labor Statistics releases the consumer price index for June. Economists forecast a 4.9% year-over-year rise, after a 5% jump in May—the fastest rate of growth since August 2008. The core CPI, which excludes volatile food and energy prices, is expected to increase 4% compared with 3.8% previously.\nThe National Federation of Independent Business releases its Small Business Optimism Index for June. Consensus estimate is for a 99.5 reading, about even with the May figure.\nWednesday 7/14\nBank of America,BlackRock,Citigroup, Delta Air Lines,PNC Financial Services Group,and Wells Fargo release earnings.\nThe Federal Reserve releases the beige book for the fifth of eight times this year. The report gathers anecdotal evidence of current economic conditions in the 12 Federal Reserve districts.\nThe BLS releases the producer price index for June. Expectations are for both the PPI and core PPI to increase 0.5% month over month. This compares with gains of 0.8% and 0.7%, respectively, in May.\nThursday 7/15\nBank of New York Mellon,Cintas,Morgan Stanley, Taiwan Semiconductor Manufacturing,Truist Financial,U.S. Bancorp,and UnitedHealth Group hold conference calls to discuss quarterly results.\nFriday 7/16\nCharles Schwab,Ericsson,Kansas City Southern, andState Streetannounce earnings.\nThe Bank of Japan announces its monetary-policy decision. The central bank is widely expected to keep its key short-term interest rate unchanged at negative 0.1%. In June, the BOJ said it would launch a climate-change plan by the end of this year, and would release a preliminary plan at its July meeting. This could take the form of higher interest rates paid to banks for green-lending measures.\nThe University of Michigan releases its Consumer Sentiment index for July. Economists forecast an 86.5 reading, slightly higher than June’s 85.5. The index is still well below its levels from just prior to the pandemic.\nThe Census Bureau reports retail-sales data for June. Consensus estimate is for a 0.5% monthly decline in spending to $617 billion, after slumping 1.3% in May.","news_type":1,"symbols_score_info":{"C":0.9,"JPM":0.9,"GS":0.9,"MS":0.9,"WFC":0.9,"BAC":0.9,"TSM":0.9}},"isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573703375513385","authorId":"3573703375513385","name":"JonLucky","avatar":"https://static.tigerbbs.com/15afb66e92e4e4d6d1a8e9b7854e9d5e","crmLevel":12,"crmLevelSwitch":1,"idStr":"3573703375513385","authorIdStr":"3573703375513385"},"content":"may the force be with you","text":"may the force be with you","html":"may the force be with you"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818877792,"gmtCreate":1630399682916,"gmtModify":1676530292007,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Still holding …come on Baba…","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Still holding …come on Baba…","text":"$Alibaba(BABA)$Still holding …come on Baba…","images":[{"img":"https://static.tigerbbs.com/47c79eec141ea959cfa4bb52c59e2839","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/818877792","isVote":1,"tweetType":1,"viewCount":1081,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":184184953,"gmtCreate":1623688989072,"gmtModify":1704208857360,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Steady …steady….prove them all wrong&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Steady …steady….prove them all wrong&nbsp;","text":"$AMC Entertainment(AMC)$Steady …steady….prove them all wrong","images":[{"img":"https://static.tigerbbs.com/16b07c8f75785e7855e7c98c4e25109f","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184184953","isVote":1,"tweetType":1,"viewCount":615,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":147769984,"gmtCreate":1626391937248,"gmtModify":1703759110593,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"Waiting the&nbsp;dip to go lower ….before buying, perhaps…","listText":"Waiting the&nbsp;dip to go lower ….before buying, perhaps…","text":"Waiting the dip to go lower ….before buying, perhaps…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/147769984","repostId":"1189934203","repostType":4,"repost":{"id":"1189934203","kind":"news","pubTimestamp":1626387468,"share":"https://ttm.financial/m/news/1189934203?lang=en_US&edition=fundamental","pubTime":"2021-07-16 06:17","market":"us","language":"en","title":"Why NVIDIA Stock Just Dropped 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189934203","media":"Motley Fool","summary":"Mizuho says NVIDIA is worth $900. Investors disagree.","content":"<blockquote>\n Mizuho says NVIDIA is worth $900. Investors disagree.\n</blockquote>\n<p><b>What happened</b></p>\n<p>Shares of graphics (and crypto-mining) chipmaker&nbsp;<b>NVIDIA</b>(NASDAQ:NVDA)tumbled for a third straight day Thursday, falling 4% in 1:25 p.m. EDT trading despite getting a boost in its price target from Wall Street bank Mizuho.</p>\n<p>And you can probably blame thecryptocurrenciesfor that.</p>\n<p><b>So what</b></p>\n<p>AsStreetInsider.comreports this morning, Mizuho Securities reiterated its \"buy\" rating on NVIDIA and upped the price target on thesemiconductor stockto $900 a share.</p>\n<p>Now with NVIDIA trading below $800 for the past two days, you might think that would be good news and would help to lift the stock, especially with Mizuho commenting that demand for both gaming consoles and gaming PCs looks \"strong\" in the second half of fiscal year 2021. The problem is, one of the biggest factors supporting NVIDIA's business (and its stock price) in recent years has been the demand for its chips for use in machines mining cryptocurrencies such as<b>bitcoin</b>(CRYPTO:BTC). And in case you haven't noticed, cryptocurrency priceshave been in a bit of a rutthe past couple of months.</p>\n<p><b>Now what</b></p>\n<p>To its credit, Mizuho addresses this objection in its note, acknowledging the slump in prices of both bitcoin and<b>Ethereum</b>(CRYPTO:ETH)and pointing out that a recent shift from requiring \"proof of work\" to \"proof of stake\" to generate Ether coins \"makes GPUs less necessary for Ethereum crypto mining\" -- potentially diminishing demand for NVIDIA's chips.</p>\n<p>Nevertheless, citing a \"rebound\" in Chinese demand for chips and the trends in gaming demand as well, the banker is increasing its revenue and earnings predictions for NVIDIA in each of the upcoming second and third fiscal quarters, and for all of fiscal 2022 and 2023 as well. Mizuho now sees NVIDIA earning as much as $16.12 per share this year and $17.70 next year.</p>\n<p>Be that as it may, and even taking Mizuho's projections at face value, at a projected valuation of nearly 43 times forward earnings and a near-term earnings growth rate of 10%, I think I'm going to have to side with the skeptics on this one.NVIDIA stock looks overpriced, and the investors selling it today ... are making the right call.</p>\n<p><img src=\"https://static.tigerbbs.com/0d07bf0013f24819eee6e7d59879d3c9\" tg-width=\"840\" tg-height=\"470\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why NVIDIA Stock Just Dropped 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy NVIDIA Stock Just Dropped 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 06:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/15/why-nvidia-stock-just-dropped-4/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mizuho says NVIDIA is worth $900. Investors disagree.\n\nWhat happened\nShares of graphics (and crypto-mining) chipmaker NVIDIA(NASDAQ:NVDA)tumbled for a third straight day Thursday, falling 4% in 1:25 p...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/15/why-nvidia-stock-just-dropped-4/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2021/07/15/why-nvidia-stock-just-dropped-4/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189934203","content_text":"Mizuho says NVIDIA is worth $900. Investors disagree.\n\nWhat happened\nShares of graphics (and crypto-mining) chipmaker NVIDIA(NASDAQ:NVDA)tumbled for a third straight day Thursday, falling 4% in 1:25 p.m. EDT trading despite getting a boost in its price target from Wall Street bank Mizuho.\nAnd you can probably blame thecryptocurrenciesfor that.\nSo what\nAsStreetInsider.comreports this morning, Mizuho Securities reiterated its \"buy\" rating on NVIDIA and upped the price target on thesemiconductor stockto $900 a share.\nNow with NVIDIA trading below $800 for the past two days, you might think that would be good news and would help to lift the stock, especially with Mizuho commenting that demand for both gaming consoles and gaming PCs looks \"strong\" in the second half of fiscal year 2021. The problem is, one of the biggest factors supporting NVIDIA's business (and its stock price) in recent years has been the demand for its chips for use in machines mining cryptocurrencies such asbitcoin(CRYPTO:BTC). And in case you haven't noticed, cryptocurrency priceshave been in a bit of a rutthe past couple of months.\nNow what\nTo its credit, Mizuho addresses this objection in its note, acknowledging the slump in prices of both bitcoin andEthereum(CRYPTO:ETH)and pointing out that a recent shift from requiring \"proof of work\" to \"proof of stake\" to generate Ether coins \"makes GPUs less necessary for Ethereum crypto mining\" -- potentially diminishing demand for NVIDIA's chips.\nNevertheless, citing a \"rebound\" in Chinese demand for chips and the trends in gaming demand as well, the banker is increasing its revenue and earnings predictions for NVIDIA in each of the upcoming second and third fiscal quarters, and for all of fiscal 2022 and 2023 as well. Mizuho now sees NVIDIA earning as much as $16.12 per share this year and $17.70 next year.\nBe that as it may, and even taking Mizuho's projections at face value, at a projected valuation of nearly 43 times forward earnings and a near-term earnings growth rate of 10%, I think I'm going to have to side with the skeptics on this one.NVIDIA stock looks overpriced, and the investors selling it today ... are making the right call.","news_type":1,"symbols_score_info":{"NVDA":0.9}},"isVote":1,"tweetType":1,"viewCount":671,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3580942055840541","authorId":"3580942055840541","name":"Jimchanfc","avatar":"https://static.tigerbbs.com/d38914f80f89dfb4ac6b61f5166d33f3","crmLevel":12,"crmLevelSwitch":0,"idStr":"3580942055840541","authorIdStr":"3580942055840541"},"content":"Everyone is waitin….","text":"Everyone is waitin….","html":"Everyone is waitin…."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":155515770,"gmtCreate":1625444666190,"gmtModify":1703741720140,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/S51.SI\">$SEMBCORP MARINE LTD(S51.SI)$</a>Hoping for a positive start to the week ….","listText":"<a href=\"https://laohu8.com/S/S51.SI\">$SEMBCORP MARINE LTD(S51.SI)$</a>Hoping for a positive start to the week ….","text":"$SEMBCORP MARINE LTD(S51.SI)$Hoping for a positive start to the week ….","images":[{"img":"https://static.tigerbbs.com/7ca9b56c6c0c11f470bbd1858e051ce1","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/155515770","isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":152776441,"gmtCreate":1625361237983,"gmtModify":1703740672532,"author":{"id":"3584582153384625","authorId":"3584582153384625","name":"Investcub","avatar":"https://static.tigerbbs.com/b34bc19b19d991e55d86b53b1e4a44ff","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584582153384625","authorIdStr":"3584582153384625"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>Should I dollar costaverage….? With the hope that it will recover?","listText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>Should I dollar costaverage….? With the hope that it will recover?","text":"$Orbital Energy Group(OEG)$Should I dollar costaverage….? With the hope that it will recover?","images":[{"img":"https://static.tigerbbs.com/9c47ccd9e2d2be84c326782ecf8272af","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/152776441","isVote":1,"tweetType":1,"viewCount":893,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573175786682331","authorId":"3573175786682331","name":"Noobilicious","avatar":"https://static.tigerbbs.com/3618820eea5b70df2f178679f213bc56","crmLevel":12,"crmLevelSwitch":1,"idStr":"3573175786682331","authorIdStr":"3573175786682331"},"content":"yes. the fundamentals of this company hasn't changed. only the stock price has...","text":"yes. the fundamentals of this company hasn't changed. only the stock price has...","html":"yes. the fundamentals of this company hasn't changed. only the stock price has..."}],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}